Scior T - Search Results

1

Recognizing pitfalls in virtual screening: a critical review.

Scior T, Bender A, Tresadern G, Medina-Franco JL, Martínez-Mayorga K, Langer T, Cuanalo-Contreras K, Agrafiotis DK. Scior T, et al. J Chem Inf Model. 2012 Apr 23;52(4):867-81. doi: 10.1021/ci200528d. Epub 2012 Apr 6. J Chem Inf Model. 2012. PMID: 22435959 Review.

2

Large compound databases for structure-activity relationships studies in drug discovery.

Scior T, Bernard P, Medina-Franco JL, Maggiora GM. Scior T, et al. Mini Rev Med Chem. 2007 Aug;7(8):851-60. doi: 10.2174/138955707781387858. Mini Rev Med Chem. 2007. PMID: 17692047 Review.

3

Integrating computational and mixture-based screening of combinatorial libraries.

Yongye AB, Pinilla C, Medina-Franco JL, Giulianotti MA, Dooley CT, Appel JR, Nefzi A, Scior T, Houghten RA, Martínez-Mayorga K. Yongye AB, et al. Among authors: scior t. J Mol Model. 2011 Jun;17(6):1473-82. doi: 10.1007/s00894-010-0850-1. Epub 2010 Sep 21. J Mol Model. 2011. PMID: 20853183

4

How to recognize and workaround pitfalls in QSAR studies: a critical review.

Scior T, Medina-Franco JL, Do QT, Martínez-Mayorga K, Yunes Rojas JA, Bernard P. Scior T, et al. Curr Med Chem. 2009;16(32):4297-313. doi: 10.2174/092986709789578213. Curr Med Chem. 2009. PMID: 19754417 Review.

5

How to Valorize Biodiversity? Let's Go Hashing, Extracting, Filtering, Mining, Fishing.

Do QT, Medina-Franco JL, Scior T, Bernard P. Do QT, et al. Among authors: scior t. Planta Med. 2015 Apr;81(6):436-49. doi: 10.1055/s-0034-1396314. Epub 2015 Feb 25. Planta Med. 2015. PMID: 25714727 Review.

6

Pharmacophore design of p38α MAP kinase inhibitors with either 2,4,5-trisubstituted or 1,2,4,5-tetrasubstituted imidazole scaffold.

Scior T, Domeyer DM, Cuanalo-Contreras K, Laufer SA. Scior T, et al. Curr Med Chem. 2011;18(10):1526-39. doi: 10.2174/092986711795328409. Curr Med Chem. 2011. PMID: 21428890 Review.

7

Interference of boswellic acids with the ligand binding domain of the glucocorticoid receptor.

Scior T, Verhoff M, Gutierrez-Aztatzi I, Ammon HP, Laufer S, Werz O. Scior T, et al. J Chem Inf Model. 2014 Mar 24;54(3):978-86. doi: 10.1021/ci400666a. Epub 2014 Feb 20. J Chem Inf Model. 2014. PMID: 24512031

8

Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review.

Scior T, Garcés-Eisele SJ. Scior T, et al. Curr Med Chem. 2006;13(18):2205-19. doi: 10.2174/092986706777935249. Curr Med Chem. 2006. PMID: 16918349 Review.

9

Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review.

Scior T, Guevara-García A, Bernard P, Do QT, Domeyer D, Laufer S. Scior T, et al. Mini Rev Med Chem. 2005 Nov;5(11):995-1008. doi: 10.2174/138955705774575264. Mini Rev Med Chem. 2005. PMID: 16307529 Review.

10

Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B.

Scior T, Guevara-García JA, Melendez FJ, Abdallah HH, Do QT, Bernard P. Scior T, et al. Drug Des Devel Ther. 2010 Sep 24;4:231-42. Drug Des Devel Ther. 2010. PMID: 20957214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page